Claritev

Claritev Invests in Klaim to Drive Growth of Provider Payment Solutions Across the U.S. and MENA Regions

Strategic Partnership Aims to Accelerate Provider Reimbursements and Expand Healthcare Payment Solutions Across the U.S. and MENA Regions Claritev Corporation a global leader in healthcare analytics and claims analysis, today announced a strategic investment in Klaim, Inc., an AI-driven healthcare…

Read MoreClaritev Invests in Klaim to Drive Growth of Provider Payment Solutions Across the U.S. and MENA Regions
Guardant Health

Guardant Health to Present Data on Blood-Based Testing’s Role in Improving Cancer Screening at ACG 2025

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data…

Read MoreGuardant Health to Present Data on Blood-Based Testing’s Role in Improving Cancer Screening at ACG 2025
Zai Lab Reports Promising Phase 1 Results for Zocilurtatug Pelitecan in Extensive-Stage Small Cell Lung Cancer, Launches Global Phase 3 Trial

Zai Lab Shares Updated Phase 1 Data for DLL3-Targeted ADC in SCLC, Launches Global Phase 3

Zai Lab Reports Promising Phase 1 Results for Zocilurtatug Pelitecan in Extensive-Stage Small Cell Lung Cancer, Launches Global Phase 3 Trial Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has released updated findings from its global Phase 1 clinical trial of…

Read MoreZai Lab Shares Updated Phase 1 Data for DLL3-Targeted ADC in SCLC, Launches Global Phase 3
IVI RMA North America to Showcase Cutting-Edge Reproductive Medicine Research at ASRM 2025

IVI RMA North America to Showcase Cutting-Edge Reproductive Medicine Research at ASRM 2025

IVI RMA North America Presents Pioneering Reproductive Medicine Studies at ASRM 2025 IVI RMA North America, a leading provider of fertility care and assisted reproductive technologies, is set to make a significant impact at the upcoming American Society for Reproductive…

Read MoreIVI RMA North America to Showcase Cutting-Edge Reproductive Medicine Research at ASRM 2025
Pulse Biosciences Enrolls First Patient in NANOCLAMP AF Study

Pulse Biosciences Enrolls First Patient in NANOCLAMP AF Study

Pulse Biosciences Enrolls First Patient in NANOCLAMP AF Study, Marking Major Milestone in Atrial Fibrillation Treatment Innovation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company pioneering next-generation medical technologies through its proprietary nPulse™ platform and Nanosecond Pulsed Field Ablation™ (nsPFA™) energy,…

Read MorePulse Biosciences Enrolls First Patient in NANOCLAMP AF Study